Jonas Verbeke
@JonasVerbeke5MD 👨⚕️-Tech enthousiast - Into stocks 📈- 🚵♀️
Similar User
@doctor_arpit
@Mvhave
@MintenLennert
@S_Dhont
@TimVanPuyvelde
@MartinaRizzoMD
@gustanpri
@BMD841
@Drwadnaha
@GabrielaNeculae
@GJvSteenbergen
@hebasaf00620808
TAVR UNLOAD just presented at TCT. First RCT in moderate AS and HFrEF. The trial did not meet the primary endpoint at last FU but early TAVR was superior to clinical surveillance at 1 year.
Among patients with asymptomatic severe aortic stenosis, early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. Full EARLY TAVR trial results: nej.md/4hjJZRc #TCT2024
#EchoDGK2024 Frank Timmermans (Gent) @echo_batman fantastic talk 🗣️ The consequences of improper MR grading for cardiac surgeons: #echofirst @iamritu @fiore_corrado @denisamuraru @eromerodorta @NMerke @MotocAndreea @PhilippLurz @DGK_org @DonalErwan @FGraziani_Grace @NadeenFaza
Impressive: 25% relative risk reduction in STEMI with cardiogenic shock using Impella!
🔥#TTEER improves left 🫀 #hemodynamics and #HeartFailure ‼️ Check out elegant #PVLoop analysis by @KP_Kresoja @PhilippLurz @RoschSeb @mvonroeder @sarabombace @A_Schoeber @AGIKinterv @YoungDgk Today @ YIA Session #DGKJahrestagung , SimPub in #EJHF : t.ly/szriu
#CardioX show your magic value
🚨 This vehicle of a friend of mine was stolen in broad daylight in Oudenaarde and later seen in Ronse. If you notice it, please make contact 🚨
🚨 This vehicle of a friend of mine was stolen in broad daylight in Oudenaarde and later seen in Ronse. If you notice it, please make contact 🚨
Very honoured to contribute to 👉Heart valve disease: at the threshold of a new era in patient management - The Lancet thelancet.com/series/valvula… 🙏🙏@hahn_rt thelancet.com/journals/lance… @GTRecerca @hgermanstrias @IcorCat @santi_roura @GalvezMonton @EFerrerSistach @victoria_vilata
Have a patient dying from acute #aorticregurgitation ? TABERNACL might help. Connecting a valvuloplasty balloon to a IABP console can function as a counter-pulsation valve. Contact authors for help or report your experience ahajournals.org/doi/10.1161/CI… @CircIntv @TheBethesdaLabs
For fellows. What all findings have you noticed here in this colour M mode through mitral valve? Sorry for poor ECG tracing
Great, Fantastic paper from @FabienPraz 👀👉 Valvular heart disease: from mechanisms to management sciencedirect.com/science/articl… @SFCvalves @AugustinCoisne
A stellar group of scientists (@hahn_rt @pattypellikka @sarano_maurice @PPibarot) will join us to answer a difficult question during the first webinar of the WG on Heart Valve Diseases of the @SIC_CARDIOLOGIA @AnnaSannino1985 Registration is free us06web.zoom.us/meeting/regist…
🔊 VExUS grading: A breakthrough in assessing perioperative fluid balance? 91% scan success rate in non-cardiac surgeries shows promise 📈 The next step? Proving it can prevent complications 🔗doi.org/10.24908/pocus…
Read about our latest research in JASE 🫀🦇🔬#echofirst
In mitral regurgitation, temporal variation of MR flow has been considered an important reason for inaccurate MR grading. We investigated whether assessing MR flow variation using a dimensionless index with echo is feasible and clinically meaningful. bit.ly/3Pz0lti
In mitral regurgitation, temporal variation of MR flow has been considered an important reason for inaccurate MR grading. We investigated whether assessing MR flow variation using a dimensionless index with echo is feasible and clinically meaningful. bit.ly/3Pz0lti
We need a standardized approach to assess pts with tricuspid regurgitation by echocardiography. Make Right Heart Remodeling in Secondary Tricuspid Regurgitation as Si... sciencedirect.com/science/articl…
1/ Ventriculoarterial coupling (#VAC) determines the harms and benefits of hemodynamic therapies. VAC describes cardiac efficiency, and offers a complementary perspective to CO, MAP and tissue perfusion. Let’s try to understand it🧵 #FOAMcc #FOAMed #MedTwitter #CardioTwitter
Of course a placebo-controlled trial of TriClip is possible. It is time for these trials to become entry standard for interventional procedures aimed at improving subjective endpoints. We should not accept substandard evidence of efficacy for procedures with both risk and cost
There is nothing wrong with QOL benefits. It is at the core of what we do as doctors. But gosh you can only show QOL benefits when a treatment is studied against a proper control arm. It's why drug trials have placebos. It's no different for procedures. Ask @rallamee
United States Trends
- 1. Cowboys 69,1 B posts
- 2. Clippers 10,6 B posts
- 3. soobin 62,6 B posts
- 4. Texans 54,6 B posts
- 5. Norman Powell 1.780 posts
- 6. Jerry 42,6 B posts
- 7. Cooper Rush 11,8 B posts
- 8. Mike McCarthy 3.221 posts
- 9. Lindy 3.464 posts
- 10. Mixon 17,6 B posts
- 11. Trey Lance 3.170 posts
- 12. Dyson Daniels 2.703 posts
- 13. sabrina 106 B posts
- 14. Keon Ellis 1.666 posts
- 15. Harden 18,5 B posts
- 16. #WWERaw 62,1 B posts
- 17. Podz 1.416 posts
- 18. Herta 34,5 B posts
- 19. #AskShadow 7.103 posts
- 20. #TheFutureIsTeal 1.040 posts
Who to follow
-
Dr Arpit
@doctor_arpit -
Maarten Vanhaverbeke
@Mvhave -
Lennert Minten
@MintenLennert -
Sebastiaan Dhont
@S_Dhont -
Tim Van Puyvelde
@TimVanPuyvelde -
Martina Rizzo
@MartinaRizzoMD -
Gustavo Prieto
@gustanpri -
Brandon M. Davis, RCIS, MBA
@BMD841 -
Dr Hassan
@Drwadnaha -
Gabriela Neculae
@GabrielaNeculae -
GJ van Steenbergen, MD, PhD
@GJvSteenbergen -
heba safwat
@hebasaf00620808
Something went wrong.
Something went wrong.